Slimming pens face coverage hurdle in Brazil Despite booming demand for GLP-1 treatments, insurers and public health system resist adding them to obesity care The pace of growth for sales of GLP-1 hormone analogues in Brazila category that includes blockbusters Wegovy and Mounjarodepends on treatment protocols for obesity that account for multiple options
In their marketing, telehealth companies claim that compounded GLP-1s in small doses starting lower than FDA-approved doses from Novo Nordisk and Eli Lilly can reduce metabolic risk, lower inflammatory markers, and even lower the risk of cognitive decline
doi:10.1111/dom.15948
Syringe dosage charts apply specifically to compounded semaglutide that comes in multi-dose vials requiring manual measurement
Together, they can suppress hunger to the point where people eat 600 to 800 calories per day without intending to, which triggers severe metabolic adaptation, muscle loss, and nutritional deficiencies
She said she wished she had been warned of those risks before
.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)
